Skip Navigation

Cardiovascular Research 2006 72(3):384-393; doi:10.1016/j.cardiores.2006.09.011
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boyd, J. H.
Right arrow Articles by Walley, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyd, J. H.
Right arrow Articles by Walley, K. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-{kappa}B dependent inflammatory response

John H. Boyd, Sumeet Mathur, Yingjin Wang, Ryon M. Bateman and Keith R. Walley*

Critical Care Research Laboratories, St. Paul's Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC, Canada, V6Z 1Y6

* Corresponding author. Tel.: +1 604 806 8136; fax: +1 604 806 8351. Email address: kwalley{at}mrl.ubc.ca

Objective: The transmembrane receptor family of Toll-like receptors (TLRs) may play a role in initiating early inflammatory and functional responses to danger signals arising from ischemia-reperfusion and inflammatory stimuli. We determined whether Toll-like receptors are expressed in cardiac tissue and whether stimulation with cognate ligands would result in a pro-inflammatory response and decreased cardiomyocyte contractility.

Methods and results: We observed mRNA expression of TLR2, TLR3, TLR4, TLR5, TLR7 and TLR9 in both whole heart tissue and a murine cardiomyocyte cell line (HL-1). Ligand activation of TLR2, TLR4 and TLR5, but not TLR3, TLR7 or TLR9, resulted in cardiomyocyte expression of the inflammatory cytokine IL-6, the chemokines KC and MIP-2, and the cell surface adhesion molecule ICAM-1. Activation of these Toll-like receptors was associated with decreased cardiomyocyte contractility. Using transfection of a nuclear factor kappa B (NF-{kappa}B)-Luciferase reporter plasmid, we found significantly increased NF-{kappa}B transcriptional activity in response to TLR2, TLR4 and TLR5 activation in cardiomyocytes. Further, a chemical inhibitor of NF-{kappa}B, pyrrolidine dithiocarbamate (PDTC), as well as transfection using a dominant negative form of IKKβ, resulted in profound reduction of the TLR-initiated pro-inflammatory response.

Conclusions: Cardiomyocytes express most known Toll-like receptors. Of these, TLR2, TLR4 and TLR5 signal via NF-{kappa}B, resulting in decreased contractility and a concerted inflammatory response.

KEYWORDS Infection/inflammation; Contractile function; Cytokines; Myocytes


* Support: Canadian Institutes of Health Research. K.R. Walley is a Michael Smith Foundation for Health Research Distinguished Scholar. J.H. Boyd is an IMPACT Postdoctoral Fellow.

Time for primary review 15 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
V. Rudolph, T. K. Rudolph, F. J. Schopfer, G. Bonacci, S. R. Woodcock, M. P. Cole, P. R.S. Baker, R. Ramani, and B. A. Freeman
Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion
Cardiovasc Res, September 2, 2009; (2009) cvp275v2.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K. Ikeda, K. Tojo, Y. Inada, Y. Takada, M. Sakamoto, M. Lam, W. C Claycomb, and N. Tajima
Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes
J. Mol. Endocrinol., June 1, 2009; 42(6): 479 - 489.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C.-H. Chu, B.-S. Tzang, L.-M. Chen, C.-J. Liu, F.-J. Tsai, C.-H. Tsai, J. A. Lin, W.-W. Kuo, D.-T. Bau, C.-H. Yao, et al.
Activation of Insulin-Like Growth Factor II Receptor Induces Mitochondrial-Dependent Apoptosis through G{alpha}q and Downstream Calcineurin Signaling in Myocardial Cells
Endocrinology, June 1, 2009; 150(6): 2723 - 2731.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Yuan, Z. Liu, T. Lim, H. Zhang, J. He, E. Walker, C. Shier, Y. Wang, Y. Su, A. Sall, et al.
CXCL10 Inhibits Viral Replication Through Recruitment of Natural Killer Cells in Coxsackievirus B3-Induced Myocarditis
Circ. Res., March 13, 2009; 104(5): 628 - 638.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-Y. Liu, W.-F. Cai, H.-Z. Yang, B. Cui, Z.-R. Chen, H.-Z. Liu, J. Yan, W. Jin, H.-M. Yan, B.-M. Xin, et al.
Bacillus Calmette-Guerin and TLR4 Agonist Prevent Cardiovascular Hypertrophy and Fibrosis by Regulating Immune Microenvironment
J. Immunol., June 1, 2008; 180(11): 7349 - 7357.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Z. Feuerstein
Cardiac RAGE in Sepsis: Call TOLL Free for Anti-RAGE
Circ. Res., May 23, 2008; 102(10): 1153 - 1154.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. H. Boyd, B. Kan, H. Roberts, Y. Wang, and K. R. Walley
S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
Circ. Res., May 23, 2008; 102(10): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Riad, S. Jager, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al.
Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice
J. Immunol., May 15, 2008; 180(10): 6954 - 6961.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Takahashi
Toll-like receptors and myocardial contractile dysfunction
Cardiovasc Res, April 1, 2008; 78(1): 3 - 4.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Knuefermann, M. Schwederski, M. Velten, P. Krings, H. Ehrentraut, M. Rudiger, O. Boehm, K. Fink, U. Dreiner, C. Grohe, et al.
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9
Cardiovasc Res, April 1, 2008; 78(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. Riad, S. Bien, M. Gratz, F. Escher, M. M. Heimesaat, S. Bereswill, T. Krieg, S. B. Felix, H. P. Schultheiss, H. K. Kroemer, et al.
Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
Eur J Heart Fail, March 1, 2008; 10(3): 233 - 243.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Natarajan, F. N. Salloum, B. J. Fisher, E. D. Ownby, R. C. Kukreja, and A. A. Fowler 3rd
Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1571 - H1580.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.